Survival from testicular cancer in England and Wales up to 2001
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6604598.pdf
Reference19 articles.
1. Bhala N, Coleman JM, Radstone CR, Horsman JM, George J, Hancock BW, Hatton MQ, Coleman RE (2004) The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patients. Clin Oncol (R Coll Radiol) 16: 40–47
2. Bhardwa JM, Powles T, Berney D, Baithun S, Nargund VH, Oliver RT (2005) Assessing the size and stage of testicular germ cell tumours: 1984–2003. BJU Int 96: 819–821
3. Bower M, Newlands E, Holden L, Rustin G, Begent R (1997) Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy. Ann Oncol 8: 477–483
4. Christian JA, Huddart RA, Norman A, Mason M, Fossa S, Aass N, Nicholl EJ, Dearnaley DP, Horwich A (2003) Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors. J Clin Oncol 21: 871–877
5. Collette L, Sylvester R, Stenning S, Fossa S, Mead G, de Wit R, de Mulder P, Neymark N, Lallemand E, Kaye S (1999) Impact of the treating institution on survival of patients with ‘poor-prognosis’ metastatic nonseminoma. J Nat Cancer Inst 91: 839–846
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. miR-21, miR-29a, and miR-106b: serum and tissue biomarkers with diagnostic potential in metastatic testicular cancer;Scientific Reports;2024-08-30
2. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis;International Urology and Nephrology;2020-10-14
3. Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma;Clinical Cancer Research;2015-10-09
4. Socio-economic inequalities in testicular cancer survival within two clinical studies;Cancer Epidemiology;2012-04
5. Time trends in testicular cancer in Croatia 1983–2007: Rapid increases in incidence, no declines in mortality;Cancer Epidemiology;2012-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3